CD8A and neoplasm: While CD4+ T cells recognize neoepitopes shown by MHC II molecules, CD8+ T cells identify neoantigens in the context of MHC I molecules expressed by tumor cells, which triggers T-cell cytotoxicity and tumor cell killing (24).